NCT06766526 Internet-based Support for Adjustment to Prostate Cancer
| NCT ID | NCT06766526 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Linkoeping University |
| Condition | Psychological Distress |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2025-01-05 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2025-01-05 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to study the efficacy of internet-based cognitive behavior therapy (ICBT) in reducing subjective distress and comorbid psychiatric symptoms in men diagnosed with prostate cancer. Participants who have been diagnosed with prostate cancer and are currently not undergoing or scheduled to undergo medical treatment will be recruited. Once recruited, they will be randomized to receive either a tailored, eight-week long ICBT intervention or an attention control group. Both group receive weekly support by a trained therapist.
Eligibility Criteria
Inclusion Criteria: * Subjectively reported psychological symptoms and problems that have come about after a prostate cancer diagnosis. * A sum score above 19 on the primary outcome measure (Kessler-10). * An age of 18 or older. * Ability to speak, read, and write Swedish. * Access to a computer/laptop/tablet/smartphone and internet access. * Sufficient computer profiency to be able to use the treatment platform. Exclusion Criteria: * Planned medical treatment or planned change in medication related to the prostate cancer during the treatment period. * Recently finished (within the past six months) medical treatment for prostate cancer. * Severe psychiatric or somatic conditions that impedes participation in the study. * Ongoing substance use problems. * Acute suicidality. * Other ongoing psychological treatment. * Psychopharmaceutic treatment that has been changed within the past month or with planned changes during the treatment phase.
Contact & Investigator
Gerhard Andersson, pHD
PRINCIPAL INVESTIGATOR
Linkoeping University
Frequently Asked Questions
Who can join the NCT06766526 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Psychological Distress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06766526 currently recruiting?
Yes, NCT06766526 is actively recruiting participants. Contact the research team at gerhard.andersson@liu.se for enrollment information.
Where is the NCT06766526 trial being conducted?
This trial is being conducted at Linköping, Sweden.
Who is sponsoring the NCT06766526 clinical trial?
NCT06766526 is sponsored by Linkoeping University. The principal investigator is Gerhard Andersson, pHD at Linkoeping University. The trial plans to enroll 180 participants.